We identify downregulation of genes related to cell–ECM interactions and TGFβ signaling in FPRMS. We confirm that TGFβ signaling enhances cell–ECM interactions in FNRMS, utilizing confocal reflection microscopy to assess ECM remodeling, and a live-cell sensor to quantitatively assess TGFβ signaling. We also show that PAX3-FOXO1 increases NOS1 expression, stimulating nitric oxide synthesis, which inhibits TGFβ signaling and reduces cell–ECM interactions. We suggest that PAX3-FOXO1 reprograms ECM anchorage dependence by suppressing cell–ECM interactions. The fusion gene can determine sensitivity to growth inhibition via targeted disruption of cell–ECM interactions or TGFβ signaling. Reduced anchorage reliance by the gene may allow cells to survive in circulation and enhance FPRMS metastatic potential.

This article is distributed under the terms as described at https://rupress.org/pages/terms102024/.
You do not currently have access to this content.